Filtered By:
Infectious Disease: SARS
Vaccination: Measles Vaccine

This page shows you your search results in order of date. This is page number 4.

Order by Relevance | Date

Total 59 results found since Jan 2013.

Intelligent system based comparative analysis study of SARS-CoV-2 spike protein and antigenic proteins in different types of vaccines
CONCLUSIONS: Our in silico study suggests a possible protective effect of Poliovirus, HIB, Hepatitis B, PCV10, Measles, Mumps, and Rubella (MMR) vaccines against COVID-19.PMID:35284579 | PMC:PMC8899449 | DOI:10.1186/s43088-022-00216-0
Source: Appl Human Sci - March 14, 2022 Category: Physiology Authors: Rabeb Touati Ahmed A Elngar Source Type: research

Localising vaccination services: Qualitative insights on public health and minority group collaborations to co-deliver coronavirus vaccines
The objective of our study was to explore how the coronavirus vaccination programme (CVP) was co-delivered between public health services and an Orthodox Jewish health organisation. Methods included 28 semi-structured interviews conducted virtually with public health professionals, community welfare and religious representatives, and household members. We examined CVP delivery from the perspectives of those involved in organising services and vaccine beneficiaries. Interview data was contextualised within debates of the CVP in Orthodox (Haredi) Jewish print and social media. Thematic analysis generated five considerations:...
Source: Vaccine - February 26, 2022 Category: Allergy & Immunology Authors: Ben Kasstan Sandra Mounier-Jack Louise Letley Katherine M Gaskell Chrissy H Roberts Neil R H Stone Sham Lal Rosalind M Eggo Michael Marks Tracey Chantler Source Type: research

Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy
Genomics. 2021 Oct 27;113(6):4109-15. doi: 10.1016/j.ygeno.2021.10.015. Online ahead of print.ABSTRACTGenetic variants of SARS-CoV-2 have been emerging and circulating in many places across the world. Rapid detection of these variants is essential since their dissemination can impact transmission rates, diagnostic procedures, disease severity, response to vaccines or patient management. Sanger sequencing has been used as the preferred approach for variant detection among circulating human immunodeficiency and measles virus genotypes. Using primers to amplify a fragment of the SARS-CoV-2 genome encoding part of the Spike pr...
Source: Genomics - October 31, 2021 Category: Genetics & Stem Cells Authors: Erick Gustavo Dorlass Karine Lima Louren ço Rubens Daniel Miserani Magalh ães Hugo Sato Alex Fiorini Renata Peixoto Helena Perez Coelho Bruna Larotonda Telezynski Guilherme Pereira Scagion Tatiana Ometto Luciano Matsumiya Thomazelli Danielle Bruna Leal Source Type: research

Recent MMR vaccination in health care workers and Covid-19: A test negative case-control study
CONCLUSION: Our results indicate that there may be a protective effect of the MMR vaccine against SARS-CoV-2 in males but not females.PMID:34187707 | DOI:10.1016/j.vaccine.2021.06.045
Source: Vaccine - June 30, 2021 Category: Allergy & Immunology Authors: Lisa Lundberg Maria Bygdell Gustaf Stukat von Feilitzen Susanne Woxenius Claes Ohlsson Jenny M Kindblom Susannah Leach Source Type: research

The Ambulance Science Podcast: Make Up Your Own Mind About the Vaccine
Get every episode of The Ambulance Science Podcast by subscribing to Apple Podcasts or Google Podcasts. Where I’m coming from (compared to most of my colleagues): Master’s in Public Health with a concentration in Health Policy from Yale Medical School.FT Faculty at GWU School of Medicine & Southern Connecticut State University MPH Program, and long-time adjunct faculty at NYMC MPH program in Health Policy.Assistant Commissioner of Health at the NYC Department of Health & Mental Hygiene during the first SARS outbreak.Served as State EMS Director, Consultant to Public Health ...
Source: JEMS Special Topics - December 14, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Podcasts Ambulance Science Source Type: news

TWiV 675: Forget what you've herd about immunity
Daniel Griffin provides a clinical report on COVID-19, then we discuss Bill Foege’s letter to CDC director Robert Redfield, the false promise of herd immunity for COVID-19, secret blueprints for SARS-CoV-2 vaccine trials released, and neuropilin-1 as a possible entry protein for the virus. Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Brianne Barker Guest: Daniel Griffin Subscribe (free): iTunes, Google Podcasts, RSS, emailBecome a patron of TWiV! Links for this episode Excess COVID-19 Deaths by Age and Race and Ethnicity (MMWR) Excess COVID-19 deaths (JAMA) SARS-CoV-2 transmission (C...
Source: This Week in Virology - MP3 Edition - October 25, 2020 Category: Virology Authors: Vincent Racaniello Source Type: podcasts

Vaccines, Antibodies and Drug Libraries. The Possible COVID-19 Treatments Researchers Are Excited About
In early April, about four months after a new, highly infectious coronavirus was first identified in China, an international group of scientists reported encouraging results from a study of an experimental drug for treating the viral disease known as COVID-19. It was a small study, reported in the New England Journal of Medicine, but showed that remdesivir, an unapproved drug that was originally developed to fight Ebola, helped 68% of patients with severe breathing problems due to COVID-19 to improve; 60% of those who relied on a ventilator to breathe and took the drug were able to wean themselves off the machines after 18...
Source: TIME: Health - April 14, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news